Dr. Andrew Morel, MD
Lead Diabetes Care
Published: April 6, 2026
Last updated: July 13, 2026
Author: Doko MD Education Team
Clinical review: Doko MD Clinical Review Team
Reviewed against official Medicare guidance
This article was checked against current Medicare.gov and CMS coverage resources on July 13, 2026. Coverage decisions remain individual.
This article was checked against current Medicare.gov and CMS coverage resources on July 13, 2026. Coverage decisions remain individual.
Medicare Part BCGMs are covered as durable medical equipment when eligible
Two pathwaysInsulin treatment or qualifying problematic hypoglycemia
6-month visitsRequired for continued coverage documentation
Many patients with type 2 diabetes ask the same question before they start the paperwork process: will Medicare actually pay for a CGM? The short answer is yes, Medicare may cover a continuous glucose monitor and related supplies under Part B, but it is not automatic. Your clinician has to prescribe the device, your records have to support the need for it, and your supplier has to bill Medicare correctly.
This article reflects Medicare coverage information verified on July 13, 2026. Because Medicare rules, contractor guidance, and supplier processes can change, confirm current details with your clinician, supplier, plan, or Medicare directly.
Short answer: Medicare may cover CGM under Part B
Yes—if you meet Medicare's requirements. Coverage is not limited to people with type 1 diabetes. People with type 2 diabetes may qualify through insulin treatment or documented problematic hypoglycemia.
According to Medicare.gov, continuous glucose monitors are covered under Medicare Part B as durable medical equipment when the patient is eligible. Medicare also notes that after the Part B deductible, patients typically pay 20% of the Medicare-approved amount if the supplier accepts assignment.
That does not mean every person with type 2 diabetes is automatically approved. The coverage rules focus on whether the patient meets the medical criteria and whether the prescribing clinician documents those criteria clearly enough for the claim to stand up.
Who may qualify in 2026
Medicare.gov states that a person with diabetes may qualify for CGM coverage if a doctor or other health care provider prescribes the device and the patient either uses insulin or has a history of problematic hypoglycemia. CMS provider guidance is more specific and is useful because it shows what suppliers and contractors actually look for.
Based on current CMS guidance, initial coverage generally requires all of the following:
- The patient has diabetes mellitus.
- The treating practitioner provides a prescription showing that the patient or caregiver has enough training to use the prescribed CGM.
- The device is prescribed according to its FDA indications for use.
- The patient is insulin-treated or has documented problematic hypoglycemia that meets Medicare's criteria.
- The treating practitioner has an in-person or Medicare-approved telehealth visit with the patient within the 6 months before ordering the CGM.
For patients with type 2 diabetes, that means insulin use is one common path to coverage, but it is not the only path. Medicare's current framework also allows coverage in certain hypoglycemia situations when the documentation is strong enough.
Path 1: Insulin treatmentThe beneficiary is treated with insulin and meets the remaining CGM criteria.
Path 2: Problematic hypoglycemiaMedical records document qualifying recurrent level 2 or a level 3 hypoglycemic event.
What Counts as Problematic Hypoglycemia
CMS describes problematic hypoglycemia in a more technical way than most patient-facing articles do. In plain terms, the documentation must show either repeated significant low blood sugar episodes that continue despite attempts to adjust the treatment plan, or a severe low blood sugar event that required help from another person.
That matters because many patients assume "I sometimes feel low" is enough for coverage. It usually is not. Medicare contractors want clinical documentation that connects the symptoms, the readings, and the treatment plan to the need for CGM.
What documentation usually matters most
In practice, coverage often depends as much on the charting as on the diagnosis itself. A strong record usually includes the diabetes diagnosis, current treatment, the reason CGM is being ordered, and a note that the patient has been evaluated in the required timeframe.
Patients should expect the clinician and supplier to pay attention to these details:
- Recent visit note: Medicare-approved in-person or telehealth evaluation within the required window.
- Prescription details: Clear prescription for the CGM and related supplies.
- Medical necessity: Record of insulin treatment or documented qualifying hypoglycemia.
- Training: Confirmation that the patient or caregiver can use the device as prescribed.
- Supplier enrollment: DME supplier should be enrolled in Medicare and ideally accept assignment.
Why Some Medicare CGM Requests Get Delayed
Many denials and delays happen because one piece of the process is incomplete, not because CGM is never covered. Common problems include an outdated visit note, vague documentation about low blood sugar history, missing prescription details, or a supplier issue.
CMS also says continued coverage requires ongoing follow-up. Their current guidance states that the treating practitioner must document an in-person or Medicare-approved telehealth follow-up every 6 months to confirm adherence and ongoing medical necessity. If that follow-up is missing, continued supply claims can be at risk.
How much patients may pay
Medicare.gov says CGM is covered under Part B and that, after the deductible, patients generally pay 20% of the Medicare-approved amount when the supplier accepts assignment. The actual amount can still vary depending on whether the patient has secondary insurance, whether the supplier participates in Medicare, and how the equipment is billed.
A practical point for patients is this: ask the supplier whether they accept assignment before moving forward. Medicare specifically notes that patients may pay more when a supplier does not accept assignment.
Original Medicare vs Medicare Advantage
If a patient has Original Medicare, the Medicare Part B rules are the core framework. If the patient has a Medicare Advantage plan, the plan still has to cover Medicare-covered services, but prior authorization steps, supplier networks, and cost-sharing details may differ. That is why two patients with similar diabetes histories can have very different administrative experiences.
This is an inference from Medicare's structure rather than a separate new coverage rule: even when the underlying benefit exists, Medicare Advantage members may still need to verify network and plan-specific requirements before they assume the process will match Original Medicare exactly.
What patients should do before applying
- Confirm whether you use insulin or may have documented hypoglycemia that could meet Medicare criteria.
- Schedule or confirm a recent in-person or Medicare-approved telehealth follow-up with your treating clinician.
- Make sure the chart note clearly explains why CGM is medically necessary for your diabetes management.
- Ask whether the supplier is enrolled in Medicare and accepts assignment.
- If you have Medicare Advantage, verify plan-specific requirements before the order is submitted.
How Doko MD Can Help
Patients often get stuck between the clinic, the supplier, and the insurer. The most common friction points are missing documentation, uncertainty about who should submit what, and confusion about whether a patient actually meets the coverage standard. That is where structured insurance support can save time.
If you are trying to understand whether you may qualify for CGM, or why a prior request stalled, our team can help you understand the next steps and connect coverage questions back to the actual diabetes care plan.
Related Services
Coverage questions
Medicare CGM Coverage FAQs
Clear answers based on current official guidance.
Does Medicare cover CGM for type 2 diabetes?
Medicare may cover a CGM and related supplies when a clinician prescribes it and the beneficiary meets eligibility, training, device-use, visit, and documentation requirements.
Do you have to use insulin for Medicare to cover a CGM?
No. Current CMS guidance also provides a pathway for beneficiaries with documented problematic hypoglycemia that meets specific criteria.
Can Medicare cover CGM without insulin?
Potentially. Records must document recurrent qualifying level 2 hypoglycemia despite treatment adjustments, or a qualifying level 3 event requiring help from another person.
How often is follow-up needed to maintain coverage?
CMS guidance requires an in-person or Medicare-approved telehealth visit every six months to document adherence and continued medical necessity.
How much does a CGM cost with Medicare?
After the Part B deductible, beneficiaries generally pay 20% of the Medicare-approved amount when the supplier accepts assignment. Medigap, Medicare Advantage, or other insurance can affect the final amount.
Does Medicare Advantage cover continuous glucose monitors?
Medicare Advantage plans must cover Medicare-covered services, but authorization, network, approved supplier, and cost-sharing rules may vary. Contact the plan before ordering.
Can the required CGM visit be completed by telehealth?
CMS permits an in-person or Medicare-approved telehealth visit when evaluating initial eligibility and for the required six-month follow-ups.
Why might a Medicare CGM request be delayed or denied?
Frequent causes include missing or outdated visit notes, incomplete eligibility documentation, prescription problems, or supplier enrollment and billing issues.
Where can I get a Medicare-covered CGM?
Use a Medicare-enrolled DME supplier or pharmacy that can bill the benefit correctly. Ask whether the supplier participates in Medicare and accepts assignment before ordering.
MC
